* West Pharmaceutical Services Inc reported quarterly adjusted earnings of $1.56 per share for the quarter ended in March, lower than the same quarter last year, when the company reported EPS of $1.98. The mean expectation of nine analysts for the quarter was for earnings of $1.27 per share. Wall Street expected results to range from $1.20 to $1.34 per share.
* Revenue fell 3% to $695.40 million from a year ago; analysts expected $670.62 million.
* West Pharmaceutical Services Inc's reported EPS for the quarter was $1.55.
* The company reported quarterly net income of $115.3 million.
* West Pharmaceutical Services Inc shares had fallen by 2.5% this quarter and gained 9.5% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 39.1% in the last three months.
* In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for West Pharmaceutical Services Inc is $400.00 This summary was machine generated from LSEG data April 25 at 01:32 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 1.27 1.56 Beat
Dec. 31 2023 1.78 1.83 Beat
Sep. 30 2023 1.86 2.16 Beat
Jun. 30 2023 1.93 2.11 Beat
Comments